4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,160.00p
   
  • Change Today:
      15.00p
  • 52 Week High: 1,188.00
  • 52 Week Low: 500.00
  • Currency: UK Pounds
  • Shares Issued: 12.81m
  • Volume: 2,186
  • Market Cap: £148.54m

Regulatory News

4basebio Plc - 4basebio announces the supply of ... 10-Apr-2024 07:00 PR Newswire
4basebio Plc - 4basebio client's Phase I clinica... 21-Mar-2024 07:00 PR Newswire
4basebio Plc - 4basebio awarded tender to delive... 01-Mar-2024 07:00 PR Newswire
4basebio Plc - Holding(s) in Company 06-Feb-2024 07:01 PR Newswire
4basebio Plc - Holding(s) in Company 06-Feb-2024 07:01 PR Newswire
4basebio Plc - Holding(s) in Company 06-Feb-2024 07:01 PR Newswire
4basebio Plc - Holding(s) in Company 06-Feb-2024 07:01 PR Newswire
4basebio Plc - Exercise of Options 06-Feb-2024 07:00 PR Newswire
4basebio Plc - Holding(s) in Company 05-Feb-2024 07:01 PR Newswire
4basebio Plc - Holding(s) in Company 05-Feb-2024 07:01 PR Newswire
4basebio Plc - Holding(s) in Company 05-Feb-2024 07:01 PR Newswire
4basebio Plc - Directors' Dealings 05-Feb-2024 07:00 PR Newswire
4basebio Plc - Long-Term Incentive Plan and Exer... 02-Feb-2024 07:00 PR Newswire
4basebio Plc - Half-year Report 21-Sep-2023 07:00 PR Newswire
4basebio Plc - Grant received from the Bill and ... 01-Aug-2023 07:00 PR Newswire
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,160.00p
Change Today 15.00p
% Change 1.31 %
52 Week High 1,188.00
52 Week Low 500.00
Volume 2,186
Shares Issued 12.81m
Market Cap £148.54m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.92% below the market average69.92% below the market average69.92% below the market average69.92% below the market average69.92% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
98.61% above the market average98.61% above the market average98.61% above the market average98.61% above the market average98.61% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
34.57% below the market average34.57% below the market average34.57% below the market average34.57% below the market average34.57% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

4basebio Dividends

No dividends found

Trades for 10-May-2024

Time Volume / Share Price
16:19 1,184 @ 1,188.00p
14:13 771 @ 1,166.00p
14:24 146 @ 1,188.00p
12:37 32 @ 1,158.50p
12:22 43 @ 1,158.50p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page